
Tirzepatide Cost 2026: $149 to $1,086/Month, Every Option Ranked (Verified July 2026)
Verified August 2026: Tirzepatide prices include $149/mo via Gala on a yearly microdose plan ($169/mo for 3 months), $299/mo via LillyDirect (brand Zepbound 2.5mg vial), $399 for the 5mg vial, $449 for 7.5mg and higher doses when refill conditions are met, $25/mo with an eligible Zepbound savings card, or $1,086/mo retail list price. Full price breakdown with 54 tracked providers.
Published provider headline prices with starting and recurring terms preserved.
Affiliate links, we earn a commission at no extra cost to you. Commercial placement; see the full price-sorted comparison on our rankings page.
Summarize this article with
In this article
- 01How Much Does Tirzepatide Cost Without Insurance?
- 02Published Tirzepatide Provider Prices and Terms
- 03How Much Does Tirzepatide Cost With Insurance?
- 04Medicare Coverage (Live Since July 2026)
- 05Tirzepatide Cost by Dose Level
- 06Brand-Name Zepbound vs Compounded Tirzepatide
- 07How to Save Money on Tirzepatide
- 08Frequently Asked Questions
- 09Sources
Verified August 2026: Tirzepatide prices include $149/month through Gala on a yearly compounded-microdose plan ($169/month on its 3-month plan), $99 first month ($280/month after) through Enhance MD (compounded), and LillyDirect brand-name Zepbound at $299 for the 2.5mg starter vial, $399 at 5mg, and $449 at 7.5mg and higher doses when refill conditions are met. Eligible commercially insured patients may pay $25/month with the Zepbound savings card; retail list price is $1,086/month without discounts. As of July 1, 2026, Medicare Part D covers Zepbound at a $50/month copay via the Medicare Bridge Program. The approved Zepbound injection produced up to 20.9% body-weight loss in SURMOUNT-1; that trial does not establish outcomes for compounded tirzepatide, and STEP-1's semaglutide result came from a separate trial population.
Quick answer by situation:
- •Featured commercial listing: Gala advertises a $149/mo yearly-plan compounded-tirzepatide microdose tier ($169/mo on its 3-month plan); it is not presented as the lowest all-in programme
- •Brand-name cash paths: LillyDirect $299/mo for the Zepbound 2.5mg starter vial, or Hers Wegovy pill medication from $149 or pen from $199 plus required $39 first-month/$149 ongoing membership
- •Commercial insurance: Zepbound savings card → $25/month copay
- •Medicare (July 2026+): $50/month via Part D Bridge Program
- •Fastest shipping: Shed $299/mo, 2-3 day delivery
- •See all options: Cheapest tirzepatide ranking | Cost calculator
This guide separates compounded, brand-name, insurance, Medicare, and retail paths and labels introductory, microdose, commitment, and manufacturer terms where known. The displayed figures are not one uniform all-in dataset: consultation, shipping, membership, dose, and renewal terms vary. Compare with semaglutide cost or see the Wegovy vs Zepbound comparison.
Comparing your options?
See every verified GLP-1 program ranked side by side on cost, safety, and care quality. The cheapest we track right now is $69/mo.
Compare all 54 GLP-1 providers →How Much Does Tirzepatide Cost Without Insurance?
Advertised compounded tiers span roughly $149 to $300 a month, LillyDirect lists $299 to $449 by Zepbound dose and refill terms, and Zepbound's list price is about $1,086. Compounded tirzepatide is not FDA-approved as a finished product. These figures are not automatically comparable all-in totals; some are microdose, introductory, commitment, or medication-only prices.
If you're paying out of pocket, there are three main ways to get tirzepatide in 2026, each with very different price points:
| Option | Monthly Cost | What You Get | Who It's Best For |
|---|---|---|---|
| Compounded tirzepatide (telehealth) | $149 to $300/mo | Not FDA-approved or established by FDA as generic, identical, or equivalent to Zepbound; formulation and concentration can vary. | Cash-pay patients considering a prescribed compounded product |
| LillyDirect vials (brand-name) | $299 to $449/mo | Brand-name Zepbound via Eli Lilly's direct program. FDA-approved. | Self-pay patients who want FDA-approved medication |
| Retail pharmacy (brand-name) | $1,086/mo Zepbound; $1,112.16/mo Mounjaro | Manufacturer list-price reference before coverage or discounts. | Patients comparing plan coverage |
Published Tirzepatide Provider Prices and Terms
These published tirzepatide prices use different billing models. Read the term beside each number and confirm the prescribed dose and complete checkout total before comparing providers:
Telos RX shows why plan terms matter: its public pages advertise tirzepatide tiers from $116 to $139 a month on the longest plans, do not publish a month-to-month rate, and its terms say early cancellation of a multi-month plan re-rates the months already used. Treat those figures as commitment-based floors rather than a comparable all-in total.
| Provider | Published Price | Type | Score | Key Details |
|---|---|---|---|---|
| Enhance MD | $99 first mo, then $280/mo | Compounded | 7.8/10 | Low-cost entry tirzepatide, combo therapy options (B12, NAD+) |
| Shed | $299/mo | Compounded | 7.8/10 | Fastest delivery (2-3 days), streamlined onboarding |
| Willow | $399/mo | Compounded | 7.5/10 | Switch between compounded and brand-name anytime |
| Henry Meds | $199/mo | Compounded | 8.4/10 | Strong medication variety, free shipping |
| Sprout Health | $199 first mo, then $249/mo | Compounded | 5.8/10 | Downgraded 2026-06-19, 2.2★ / BBB F verified reputation |
| Embody | from $129/mo on a selected plan | Compounded | 7.3/10 | Oral tirzepatide gum at $329 for one month. Metabolic report + 24/7 support |
| Ro (brand-name) | $349/mo | Brand | 7.2/10 | Zepbound via insurance billing, $99/mo with coverage |
For a live list that preserves exact drug-tier qualifiers, see our tirzepatide price comparison. Or take our 7-question match quiz for a fit-based shortlist.
Join the list for the GLP-1 Letter.
We re-verify every price on this site against the provider's own live page and check every program against the FDA warning letter database. Join the list and you will hear from us when that work turns up something worth an email. No promised schedule until we are actually keeping one. Unsubscribe anytime.
No affiliate spam. No retargeting pixels. Unsubscribe in one click.
How Much Does Tirzepatide Cost With Insurance?
Tirzepatide costs $25/mo if your plan covers Zepbound and you use the Zepbound savings card, but that card caps at $1,300 a year. Without the card, a covered plan leaves a specialty copay of $50 to $150/mo that varies by plan.
If you have commercial health insurance, tirzepatide can cost significantly less. Here's how insurance changes the math:
| Scenario | Monthly Cost | How to Access |
|---|---|---|
| Insurance covers Zepbound + savings card | $25/mo | Apply for savings card at zepbound.lilly.com/savings (max $1,300/year) |
| Insurance covers Zepbound, no savings card | $50 to $150/mo | Standard specialty drug copay varies by plan |
| Insurance doesn't cover, savings card only | $499/mo | Savings card without coverage provides a reduced price |
| Telehealth with insurance billing (Ro, Fridays) | $99 to $249/mo | Provider bills insurance directly, you pay the remainder |
| No insurance, compounded telehealth | $99 to $280/mo | Cash-pay through providers like Enhance MD ($99 first month), Shed ($299), or Sprout Health ($199 first month) |
Medicare Coverage (Live Since July 2026)
On July 1, 2026, Medicare Part D begins covering brand-name Zepbound (tirzepatide) through the GLP-1 Bridge Demonstration program. The program sets a fixed $50/month copay for qualifying beneficiaries with a BMI of 30+ (or 27+ with a weight-related comorbidity). This is a landmark shift, an estimated 3.8 million Part D enrollees may become newly eligible for tirzepatide coverage.
Important: Medicare will only cover FDA-approved brand-name Zepbound, not compounded tirzepatide. Read our full guide to Medicare GLP-1 coverage in 2026 for eligibility details and enrollment steps.
Editor's Top Pick
Embody
from $69/mo · 7.3/10 · Compounded
Online weight-loss program that ships compounded GLP-1 medication to your door. Modern Metabolic Medicine, Inc. runs the storefront and OpenLoop Health supplies the clinical network on the current site. Embody now advertises compounded semaglutide from $79 and GLP-1 + GIP from $129; its FAQ says the chosen rate holds within a selected 4-, 12-, 24- or 52-week plan. Its standout is oral tirzepatide gum for people who do not want injections.
Tirzepatide Cost by Dose Level
Tirzepatide is prescribed as a once-weekly injection with gradual dose escalation. Telehealth billing varies by provider and plan; LillyDirect's Zepbound self-pay price varies by strength and refill timing:
| Dose | Treatment Phase | LillyDirect Self-Pay | Telehealth Published Range (not necessarily all-in) |
|---|---|---|---|
| 2.5 mg/week | Starting dose (weeks 1-4) | $299/mo | $149 to $249/mo |
| 5 mg/week | Escalation (weeks 5-8) | $399/mo | $149 to $300/mo, terms vary |
| 7.5 mg/week | Escalation (weeks 9-12) | $449/mo with stated refill timing | $149 to $300/mo, terms vary |
| 10 mg/week | Escalation or maintenance | $449/mo with stated refill timing | $149 to $300/mo, terms vary |
| 12.5 mg/week | Escalation (weeks 17-20) | $449/mo with stated refill timing | $149 to $300/mo, terms vary |
| 15 mg/week | Maximum maintenance dose | $449/mo with stated refill timing | $149 to $300/mo, terms vary |
The SURMOUNT-1 trial found that the 15mg dose produced up to 22.5% body weight loss at 72 weeks, the highest of any FDA-approved weight loss medication. Most patients reach their maintenance dose between months 4-6.
Not sure which GLP-1 program is right for you?
Take the 60-second quiz, we'll match you against 54 verified providers on your goals, budget, and medication preference, then surface your top 3.
Take the 60-sec QuizBrand-Name Zepbound vs Compounded Tirzepatide
The biggest pricing decision with tirzepatide is whether to go brand-name or compounded. Here's the trade-off:
| Factor | Brand-Name Zepbound | Compounded Tirzepatide |
|---|---|---|
| Monthly cost (self-pay) | $299 to $449 (LillyDirect) | $149 to $300 (telehealth) |
| FDA approved | Yes | No (pharmacy-compounded under 503A/503B) |
| Insurance eligible | Often, check your plan | Rarely covered |
| Quality assurance | Manufactured by Eli Lilly under strict cGMP | Quality varies by compounding pharmacy |
| Regulatory risk | None | FDA has taken enforcement actions against some compounders |
| Savings card available | Yes, $25/mo with coverage | No manufacturer savings cards |
For a deeper comparison, read our brand-name vs compounded GLP-1 guide. If you are considering a compounded product, use our public-record checker to review sourced FDA letters and available pharmacy disclosures; it does not certify a provider, prescription, pharmacy, or batch.
How to Save Money on Tirzepatide
- •Apply for the Zepbound savings card, If you have commercial insurance that covers Zepbound, the manufacturer savings card reduces your copay to $25/month (max benefit $1,300/year). Apply at zepbound.lilly.com/savings.
- •Compare all-in telehealth prices, Don't compare intro prices. Use our cheapest tirzepatide ranking which shows what you actually pay each month.
- •Note on compounded semaglutide, FDA resolved the semaglutide shortage on February 21, 2025, and the agency's shortage-based enforcement-discretion periods ended April 22 for 503A pharmacies and May 22 for 503B outsourcing facilities. That did not create a blanket federal ban on every patient-specific prescription; compliance depends on the applicable section 503A or 503B conditions. See our post-shortage semaglutide guide for the distinction.
- •Ask about HSA/FSA, Most GLP-1 programs qualify as FSA/HSA-eligible medical expenses. Providers like Willow and Sprout Health can provide superbills for reimbursement.
- •Wait for Medicare (if eligible), If you're 65+, the July 2026 Medicare coverage at $50/month may be cheaper than any telehealth option.
- •Use the cost calculator, Our cost calculator estimates your total spend based on your insurance status, preferred medication, and treatment duration.
Frequently Asked Questions
What is the cheapest way to get tirzepatide without insurance? There is no single lowest comparable total across every formulation and plan. Gala advertises a $149/month yearly-plan compounded-tirzepatide microdose tier ($169/month on its 3-month plan); Enhance MD starts at $99 for the first month and then $280/month; Shed advertises $299/month. For FDA-approved Zepbound without insurance, LillyDirect starts at $299/month for 2.5 mg. Confirm dose, consultation, shipping, membership, and commitment terms before ranking these figures.
Is compounded tirzepatide safe? Compounded tirzepatide is not FDA-approved, and FDA has not reviewed a compounded product as identical or equivalent to Zepbound. Formulation, concentration, sterility controls, and instructions can vary. Ask for the dispensing pharmacy's name, confirm its state license or 503B registration as applicable, and verify the exact mg/mL and syringe units with the prescriber or pharmacist. Our warning and transparency checker summarizes selected public records; it does not certify a provider or medication as safe.
How much does tirzepatide cost per month on average? The average monthly cost for tirzepatide through telehealth is $200 to $300 without insurance. Brand-name Zepbound averages $300 to $450 self-pay through LillyDirect. With insurance and a savings card, costs can drop to $25/month.
Will tirzepatide get cheaper in 2026? It depends on coverage and manufacturer programs. Eligible Medicare Part D patients pay a $50/month Bridge copay for brand-name Zepbound. Competition from oral GLP-1s may also affect pricing; Foundayo currently runs $149-$349/month through LillyDirect depending on dose and, at 14.5 or 17.2 mg, whether it is refilled within 45 days.
Is tirzepatide worth the extra cost over semaglutide? In clinical trials, tirzepatide produced significantly more weight loss than semaglutide, 20.2% vs 13.7% in the SURMOUNT-5 head-to-head trial. Whether the $50 to $150/month premium is worth it depends on your goals and budget. Read our full comparison.
Sources
- SURMOUNT-1: Tirzepatide for Treatment of Obesity, New England Journal of Medicine, 2022
- SURMOUNT-5: Tirzepatide vs Semaglutide for Weight Loss, New England Journal of Medicine, 2025
- Zepbound Prescribing Information, Eli Lilly / FDA Label
- LillyDirect Self-Pay Program, Eli Lilly
- Zepbound Savings Card, Eli Lilly
- CMS GLP-1 Bridge Demonstration Program, Centers for Medicare & Medicaid Services, 2026
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting any medication. Information is current as of the publication date but may change.
Affiliate Disclosure: Some links in this article are affiliate links. We may earn a commission if you sign up through our links, at no extra cost to you.
Ready to start? Our Top Pick is Embody
Our featured pick is listed at from $69/mo, or run the numbers across 54 providers first.
Featured affiliate pick, we may earn a commission · scores set by our methodology, not payment
Compare every GLP-1 program in one place
See all 54 verified providers ranked side by side on price, medication, and our independent score, or jump straight to the cheapest verified prices.
Medicare & GLP-1
Medicare GLP-1 Coverage Guide
Saw Medicare mentioned in "Tirzepatide Cost 2026: $149 to $1,086/Month, Every Option Ranked (Verified July 2026)"? Here's exactly what's covered, who qualifies, and how the $50/mo Bridge copay works from July 1, 2026.
Read the Medicare Coverage Guide →Compounded Tirzepatide in 2026: Prices, Safety Questions, and FDA Rules
Cost & InsuranceMedicare GLP-1 Bridge Enrollment Guide 2026: $50 Copay for Foundayo, Wegovy & Zepbound
Side Effects & SafetyZepbound Side Effects (2026): Nausea 29%, Diarrhea 23%, Vomiting 13%, Full Guide with SURMOUNT Trial Data
Keep exploring
- →Provider Rankings
- →Cheapest Providers
- →Take the Match Quiz
- →Weight Loss Predictor
- →Full Cost Guide
- →Cost Calculator
What the doctors say
Verbatim, independently sourced statements from named physicians and medical bodies, real clinicians quoted with their sources, not a single paid reviewer. General clinical context, not an endorsement of any provider.
“While compounding can play an appropriate role when used to meet the specific needs of an individual patient, the large-scale production and marketing of compounded versions of these medicines raises serious safety risks when products have not undergone the rigorous scientific and regulatory review required for FDA-approved therapies.”
“It's not just filling out a form online and then having some random healthcare provider sign off on it. There are concerns with some of these online programs that there's not a proper evaluation, there's not a baseline, and there's not proper supervision.”
“Compounded drugs can be important for overcoming shortages or meeting unique patient needs, but compounders should not try to compound drugs in a way that circumvents FDA's approval process.”
Quotes are general medical commentary about GLP-1 medications, independently sourced and not solicited by GLP-1 Picks. They are not an endorsement of any provider, our provider scores are set solely by our published methodology.